Testing and Diagnosis
ZERO's Position on Testing
ZERO believes the PSA test is part of the overall picture of evaluating a man's risk for prostate cancer. The more risk factors you have, the more important it is to start a conversation with your doctor and get tested on an annual basis. Every cancer case is individualized and so are healthcare decisions regarding talking to your doctor about testing for prostate cancer.
Every man has some level of risk for getting prostate cancer, yet many other factors also make some men more susceptible to prostate cancer than others.
Prostate cancer doesn't show its face early on, so without symptoms it can be nearly impossible to detect in the early stages.
Testing and Education are the keys to Beating Prostate Cancer!
The PSA test and advances in treatment have led to a 40 percent reduction in prostate cancer deaths since the mid-1990s, and 90 percent of all prostate cancers are now discovered before they spread outside the gland. The survival rate is nearly 100 percent when prostate cancer is detected early, while the tumor is still localized and hasn’t spread.
Prostate Specific Antigen (PSA) is a protein made in the prostate gland. Normally, very little should be found in the blood. Rising levels of PSA in the blood indicate a problem with the prostate, which could be cancer but could also be an enlarged prostate (BPH).
An abnormal PSA test or DRE exam indicates the need for further testing, including a biopsy or MRI, to determine if the abnormal readings indicate prostate cancer.
Almost all men suffer from some prostate enlargement, or benign prostatic hyperplasia (BPH), as they grow older.
Two major issues confront prostate cancer testing research: determining if you have prostate cancer and then determining whether your case is aggressive and requires immediate treatment. A number of new and far more accurate prostate cancer tests are right around the corner, if the government supports funding for several critical research programs.